Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.
The rescheduling of marijuana may remove regulatory hurdles and expand the breadth of research beyond pain management.